
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.820 | 1.820 | 0.000 |
Shares | 98.180 | 98.180 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.985 | 13.181 |
Price to Book | 1.881 | 1.814 |
Price to Sales | 1.426 | 1.180 |
Price to Cash Flow | 8.335 | 7.659 |
Dividend Yield | 3.038 | 3.038 |
5 Years Earnings Growth | 9.078 | 9.178 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 29.050 | 18.665 |
Healthcare | 13.920 | 14.819 |
Industrials | 12.030 | 12.406 |
Consumer Defensive | 10.980 | 9.592 |
Technology | 9.550 | 14.394 |
Energy | 6.850 | 5.441 |
Utilities | 5.590 | 4.463 |
Communication Services | 5.370 | 8.146 |
Basic Materials | 3.380 | 5.444 |
Consumer Cyclical | 3.280 | 10.046 |
Number of long holdings: 91
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Charles Schwab | US8085131055 | 3.46 | 95.83 | +0.01% | |
NatWest Group | GB00BM8PJY71 | 3.42 | 562.40 | -0.07% | |
UBS Group | CH0244767585 | 2.91 | 32.32 | +1.38% | |
Medtronic | IE00BTN1Y115 | 2.29 | 92.71 | +1.77% | |
Bank of America | US0605051046 | 2.10 | 49.48 | +2.53% | |
Goldman Sachs | US38141G1040 | 2.07 | 741.89 | +3.62% | |
Aon | IE00BLP1HW54 | 2.07 | 375.10 | -0.05% | |
Pfizer | US7170811035 | 1.97 | 25.88 | +0.54% | |
Northern Trust | US6658591044 | 1.96 | 130.06 | +2.16% | |
Cigna | US1255231003 | 1.92 | 304.35 | +1.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS Global Equity Fund USD Acc | 431.97M | 8.70 | 10.99 | 8.00 | ||
MFS Global Concentrated Equity Funu | 126.51M | 7.39 | 7.32 | 8.26 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review